As Calls For Patent Sharing To Fight Pandemic Intensify, Manufacturing May Be Bigger Issue
Executive Summary
Scientists and lawyers ask companies to temporarily license their IP for free, as others advocate compulsory licenses; real issue may be the ability to make a COVID-19 treatment or vaccine widely available.